Search Results

You are looking at 151 - 160 of 5,010 items for :

  • "treatment" x
  • Medical and Health Sciences x
  • Refine by Access: All Content x
Clear All

140 145 Silvestri, G. A., Rivera, P.: Targeted therapy for the treatment of Advanced Non-small Cell Lung Cancer. A review of the Epidermal Growth Factor Receptor

Restricted access
Orvosi Hetilap
Authors: Zsófia Miltényi, Zsófia Simon, Edit Páyer, László Váróczy, Lajos Gergely, and Árpád Illés

Josting, A., Rueffer, U., Franklin, J. és mtsai: Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group. Blood, 2000, 96 , 1280

Restricted access
Interventional Medicine and Applied Science
Authors: A. Doros, B. Nemes, Z. Máthé, A. Németh, E. Hartmann, Á. P. Deák, Zs. F. Lénárd, D. Görög, I. Fehérvári, Zs. Gerlei, J. Fazakas, Sz. Tóth, and L. Kóbori

Interventional treatment of hepatic artery stenosis after orthotopic liver transplantation with balloon-expandable coronary stent Transplant Proc 39 3245 3250

Restricted access

Henzen, C., Rock, M., Schnieper, C. et al.: Heparin and insulin in the treatment of acute hypertriglyceridemia induced pancreatitis. Schweiz. Med. Wochenschr., 1999, 129 , 1242–1248. Schnieper C

Restricted access

Introduction The last decade has witnessed a resurgence of interest in serotonergic psychedelics, such as lysergic acid diethylamide (LSD) and psilocybin, for the treatment of a range of psychopathologies. Whilst individuals self-medicate with

Open access

Scotto, G., Grimaldi, M.: Effectiveness of leukocyte interferon-alpha treatment in patients with chronic hepatitis C not responsive to recombinant interferon. Dig. Dis. Sci., 1998, 43 , 2173–2176. Grimaldi

Restricted access

. , Kakuk , T. , Henke , C. , Rector , D. and Tesar , F. ( 1984 ): Clinical evaluation of amitraz as a treatment for canine demodicosis . Vet. Parasitol. 16 , 335 – 341 . Folz

Restricted access

I. Maschek 1996 Radiation treatment of pharmaceuticals Radiat Phys Chem 47 515 517 . 21

Restricted access

2020. In Canada, 60% of patients with hypertension are controlled and treated [ 13 , 14 ]. This increases the need to manage the disease. Among the factors influencing the management of the everincreasing hypertension cases is adherence to treatment

Open access

. Breithardt 2003 Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double blind, randomised controlled trial (E-SIRIUS) Lancet

Restricted access